Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
BMC Complementary and Alternative Medicine|April 10, 2013
Cytotoxic and antimicrobial activity of selected Cameroonian edible plantsJean Paul Dzoyem, Santosh Kumar Guru, Constant Anatole Pieme, et al.
European Journal of Medicinal Chemistry|March 20, 2012
Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compoundsSrinivas Jada, Mahendhar Reddy Doma, Parvinder Pal Singh, et al.
Bioorganic Chemistry|June 5, 2021
1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureusFatima Naaz, Arif Khan, Anchala Kumari, et al.
European Journal of Medicinal Chemistry|January 29, 2011
Anti-tubercular agents. Part 6: synthesis and antimycobacterial activity of novel arylsulfonamido conjugated oxazolidinonesAhmed Kamal, Rajesh V C R N C Shetti, Shaik Azeeza, et al.
Microbial Pathogenesis|June 26, 2017
Antimicrobial investigation of selected soil actinomycetes isolated from unexplored regions of Kashmir Himalayas, IndiaAabid Manzoor Shah, Shakeel-U-Rehman, Aehtesham Hussain, et al.
European Journal of Medicinal Chemistry|August 14, 2010
Anti-tubercular agents. Part 5: synthesis and biological evaluation of benzothiadiazine 1,1-dioxide based congenersAhmed Kamal, Rajesh V C R N C Shetti, Shaik Azeeza, et al.
ACS Infectious Diseases|December 5, 2023
Exploring the Antibacterial Potential of Semisynthetic Phytocannabinoid: Tetrahydrocannabidiol (THCBD) as a Potential Antibacterial Agent against Sensitive and Resistant Strains of Staphylococcus aureusPankaj Singh Cham, Deepika, Rahul Bhat, et al.
Organic & Biomolecular Chemistry|February 12, 2015
Synthesis of new generation triazolyl- and isoxazolyl-containing 6-nitro-2,3-dihydroimidazooxazoles as anti-TB agents: in vitro, structure-activity relationship, pharmacokinetics and in vivo evaluationGurunadham Munagala, Kushalava Reddy Yempalla, Samsher Singh, et al.
Bioorganic & Medicinal Chemistry Letters|November 12, 2013
Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazolesAhmed Kamal, Syed Mohammed Ali Hussaini, Shaikh Faazil, et al.
Pulmonary Pharmacology & Therapeutics|November 28, 2017
Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico-in-vitro-in-vivo approachAsmita Magotra, Anjna Sharma, Samsher Singh, et al.
Pageof 6